» Articles » PMID: 30481777

Skeletal Morbidity in Children and Adolescents During and Following Cancer Therapy

Overview
Publisher Karger
Date 2018 Nov 28
PMID 30481777
Citations 22
Authors
Affiliations
Soon will be listed here.
Abstract

Skeletal abnormalities are common in children and adolescents diagnosed and treated for a malignancy. The spectrum ranges from mild pain to debilitating osteonecrosis and fractures. In this review, we summarize the impact of cancer therapy on the developing skeleton, provide an update on therapeutic strategies for prevention and treatment, and discuss the most recent advances in musculoskeletal research. Early recognition of skeletal abnormalities and strategies to optimize bone health are essential to prevent long-term skeletal sequelae and diminished quality of life in childhood cancer survivors.

Citing Articles

Epidemiology of multimorbidity in childhood cancer survivors: a matched cohort study of inpatient hospitalisations in Western Australia.

Abdalla T, Ohan J, Ives A, White D, Choong C, Bulsara M BJC Rep. 2025; 3(1):15.

PMID: 40082620 PMC: 11906868. DOI: 10.1038/s44276-024-00114-1.


Paediatric cancer survivors: lean mass attenuates negative impact of watching television on bone.

Marmol-Perez A, Ubago-Guisado E, Llorente-Cantarero F, Cadenas-Sanchez C, Rodriguez-Solana A, Gil-Cosano J Pediatr Res. 2024; .

PMID: 39516571 DOI: 10.1038/s41390-024-03714-2.


Bone health in childhood cancer survivors, is there really a problem? Pitfalls of assessment, calculating risk, and suggested surveillance and management for osteonecrosis and low and very low bone mineral density.

de Winter D, Neggers S, van den Heuvel-Eibrink M, van Atteveld J Endocr Connect. 2024; 13(12).

PMID: 39437150 PMC: 11623254. DOI: 10.1530/EC-24-0487.


Osteoporosis and Bone Fragility in Children: Diagnostic and Treatment Strategies.

Cannalire G, Biasucci G, Bertolini L, Patianna V, Petraroli M, Pilloni S J Clin Med. 2024; 13(16).

PMID: 39201093 PMC: 11355204. DOI: 10.3390/jcm13164951.


Causality between Sex Hormones and Bone Mineral Density in Childhood: Age- and Tanner-Stage-Matched Sex Hormone Level May Be an Early Indicator of Pediatric Bone Fragility.

Kim S, Kim S, Kim S, Cho W, Cho K, Jung M Biomedicines. 2024; 12(6).

PMID: 38927380 PMC: 11200954. DOI: 10.3390/biomedicines12061173.


References
1.
Kechli A, Wilimas J, Pui C, Park V, Tonkel S, Deitcher S . Factor V Leiden and other hypercoagulable state mutations are not associated with osteonecrosis during or after treatment for pediatric malignancy. J Pediatr. 1999; 134(3):310-4. DOI: 10.1016/s0022-3476(99)70455-5. View

2.
Valimaki M, Kinnunen K, Volin L, Tahtela R, Loyttyniemi E, Laitinen K . A prospective study of bone loss and turnover after allogeneic bone marrow transplantation: effect of calcium supplementation with or without calcitonin. Bone Marrow Transplant. 1999; 23(4):355-61. DOI: 10.1038/sj.bmt.1701586. View

3.
Socie G, Curtis R, Deeg H, Sobocinski K, Filipovich A, Travis L . New malignant diseases after allogeneic marrow transplantation for childhood acute leukemia. J Clin Oncol. 2000; 18(2):348-57. DOI: 10.1200/JCO.2000.18.2.348. View

4.
Nysom K, Holm K, Michaelsen K, Hertz H, Jacobsen N, Muller J . Bone mass after allogeneic BMT for childhood leukaemia or lymphoma. Bone Marrow Transplant. 2000; 25(2):191-6. DOI: 10.1038/sj.bmt.1702131. View

5.
Wei S, Esmail A, Bunin N, Dormans J . Avascular necrosis in children with acute lymphoblastic leukemia. J Pediatr Orthop. 2000; 20(3):331-5. View